Authors : Carata-Dejoianu T.1, Cernea A-M.1, Constantin M.1
1 "Victor Babes" Clinic, Bucharest
Introduction : Given the increasing number of international travelers, as
tourists or with professional goals, there is a rising concern to minimize the risk of illness from
infectious diseases; therefore international health organizations (WHO, CDC) recommend certain
immunizations before traveling. These recommendations are followed by employing companies, travel
agencies, insurance companies, or by patients themselves. Among the most requested immunizations
prior to travel, especially to destinations outside Europe, are those for hepatitis A and B.
This paper aims to examine the real need and the benefits of vaccination for viral hepatitis, prior
the trip abroad, taking into consideration the prevalence of protective antibodies in the Romanian
population.
Materials and methods : We have studied 146 patients presented in DTC "Victor
Babes" from March 01, 2008 to February 28, 2010, trying to determine the opportunity of the vaccination
for hepatitis A and/or B, when traveling abroad. Of the patients included in the study 40 were women
(28 %), and 106 men (72 %). The distribution on age groups was the following : 48 (32.87 %) patients
between 15 and 30 years, 68 (46.58 %) patients between 30 and 45 years and 30 (20.55 %) patients over
45 years. The patients have reported no history of acute hepatitis and they did not have any previous
vaccination. All of them have requested the vaccination for hepatitis A and B.
Conclusion : Of the total 146 patients :
- 105 (71.91 %) showed protective antibodies to hepatitis A, vaccination being no longer necessary;
- 23 patients (15.75 %) showed protective titers of anti HBs and 5 (3.42 %) showed positive HBs
antigen, vaccination is not recommended;
- 16 patients (10.95 %) had antibodies to both VHA and VHB, immunization is not required for either
of the viruses.
Given the prevalence of asymptomatic infection with hepatitis virus, the lack of records on previous
immunizations, the possible detection of chronic infection with hepatitis B, the vaccination costs
versus the cost of serological investigations, the precise determination of serology is necessary
before beginning vaccination for hepatitis. Unfortunately the late presentation to the doctor makes
this approach difficult.
Keywords : travel, antibodies, hepatitis, vaccination, prevention.